创伤性血胸治疗研究进展  

Research progress in the treatment of traumatic hemothorax

作　　者：辛少伟 辛向兵 冯杨波 王涛 韩勇 Xin Shaowei;Xin Xiangbing;Feng Yangbo;Wang Tao;Han Yong(Department of Thoracic Surgery, the Second Affiliated Hospital of the Air Force Military Medical University, Xi'an 710038, China)

机构地区：[1]空军军医大学第二附属医院胸腔外科,西安710038

出　　处：《中华胸心血管外科杂志》2019年第7期438-442,共5页Chinese Journal of Thoracic and Cardiovascular Surgery

摘　　要：创伤性血胸是胸部创伤中常见的病症,治疗不当可发生持续失血、凝固性血胸和脓胸等,危及患者生命。创伤性血胸治疗尚无公认的指南或共识。本文重点回顾近年来关于创伤性血胸的治疗进展,总结创伤性血胸治疗领域最新成果,为临床医师临床决策提供证据。Traumatic hemothorax is a common disease in chest trauma. If it is not treated properly and effectively, it will lead to continuous blood loss, clotted hemothorax, empyema and other life-threatening conditions. Because of no universally accepted guide or consensus in the treatment of traumatic hemothorax, clinicians often choose different ways to treat different degrees and types of traumatic hemothorax according to their habits and experience. This article focus on recent studies on the treatment of traumatic hemothorax, summarize the latest achievements in the field of traumatic hemothorax, provide evidence for clinicians' clinical decision-making, and find the current insufficiency of traumatic hemothorax and the direction for further research.

关 键 词：创伤性血胸 治疗不当 凝固性血胸 胸部创伤 临床决策 临床医师 

分 类 号：R655[医药卫生—外科学]